Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Innate Pharma    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about INNATE PHARMA
01/05Sanofi Selects Innate's First NK Cell Engager as Anti-Tumor Drug Candidate fo..
MT
01/05Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Devel..
GL
01/05INNATE PHARMA : first NK cell engager selected by Sanofi as drug candidate for d..
GL
01/04Innate Pharma to Participate in Upcoming Investor Conferences
GL
01/04INNATE PHARMA : to participate in upcoming investor conferences
GL
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50..
MT
2020INNATE PHARMA : to return US and EU Lumoxiti commercialization rights to AstraZe..
AQ
2020SECTOR UPDATE : Health Care Stocks Trade Lower Premarket Friday
MT
2020INNATE PHARMA S A : to Give Up License to AstraZeneca's Leukemia Drug Due to Low..
MT
2020Innate Pharma to Return US and EU Lumoxiti Commercialization Rights to AstraZ..
GL
2020INNATE PHARMA :  Innate Pharma to return US and EU Lumoxiti commercialization ri..
GL
2020Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combinat..
GL
2020INNATE PHARMA : to Present Additional Efficacy Data for Monalizumab in Combinati..
AQ
2020INNATE PHARMA :  Innate Pharma to present additional efficacy data for monalizum..
GL
More most relevant news
All news about INNATE PHARMA
01/05SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday
MT
01/05ETF PREVIEW : ETFs, Futures Log Gains Ahead of Georgia Senate Election Runoff Re..
MT
01/05SANOFI : Innate Pharma Shares Rise as Sanofi Selects its Anti-Tumor Drug Candida..
MT
01/05Sanofi Selects Innate's First NK Cell Engager as Anti-Tumor Drug Candidate fo..
MT
01/05Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Devel..
GL
01/05INNATE PHARMA : first NK cell engager selected by Sanofi as drug candidate for d..
GL
01/04Innate Pharma to Participate in Upcoming Investor Conferences
GL
01/04INNATE PHARMA : to participate in upcoming investor conferences
GL
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50..
MT
More news
News in other languages on INNATE PHARMA
01/05INNATE PHARMA : sa collaboration avec Sanofi progresse, le cours en profite
01/05INNATE PHARMA : plus forte hausse du SRD à la mi-séance du mardi 5 janvier 2021
01/05STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe
01/05INNATE PHARMA : La valeur du jour à Paris INNATE PHARMA débute bien l'année
01/05Les valeurs à suivre aujourd'hui à la Bourse de Paris
01/05Boris confine, Donald trompe
01/05INNATE PHARMA : la collaboration avec SANOFI avance bien
01/05EN DIRECT DES MARCHES : Alstom, Saint-Gobain, Crédit Agricole, Nexity, Innate, L..
01/05INNATE : un anticorps progresse dans la recherche de Sanofi
01/05INNATE PHARMA : Un premier anticorps multispécifique engageant les cellules NK d..
Analyst Recommendations on INNATE PHARMA
2020INNATE PHARMA S A : SVB Leerink Downgrades Innate Pharma to Market Perform From ..
MT
2020INNATE PHARMA S A : HC Wainwright Adjusts Innate Pharma's Price Target to $11.50..
MT
2020Goldman Sachs Starts Innate Pharma at Neutral With $4.75 Price Target
MT
2015France's 'economic patriotism' is not what it seems
RE
More recommendations
Press releases
01/05Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Devel..
GL
01/05INNATE PHARMA : first NK cell engager selected by Sanofi as drug candidate for d..
GL
01/04Innate Pharma to Participate in Upcoming Investor Conferences
GL
01/04INNATE PHARMA : to participate in upcoming investor conferences
GL
2020INNATE PHARMA : to return US and EU Lumoxiti commercialization rights to AstraZe..
AQ
More press releases
Upcoming event on INNATE PHARMA